Coagulation and fibrinolytic parameters in normal and hypertensive pregnancies

Journal of Maternal-Fetal Investigation

Volumn 7, Issue 3, 1997, Pages 129-132

  Ricci, Giuseppe ^a   Cerneca, Federico ^b   Simeone, Roberto ^a   Alberico, Salvatore ^a   Malisano, Monica ^a   Guaschino, Secondo ^b  

^a UNIVERSITY OF TRIESTE   (Italy)

^b INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

Author keywords

Hemostasis; Hypertension; Pregnancy

Indexed keywords

ALKALINE PHOSPHATASE; ALKALINE PHOSPHATASE PLACENTA ISOENZYME; ANTITHROMBIN III; FIBRINOGEN; MARKER; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN C; PROTEIN S; PROTHROMBIN; PROTHROMBIN ACTIVATION FRAGMENT; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG; URIC ACID;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FIBRINOGEN BLOOD LEVEL; FIBRINOLYSIS; HEMOSTASIS; HUMAN; MATERNAL HYPERTENSION; PARTIAL THROMBOPLASTIN TIME; PATIENT MONITORING; PREECLAMPSIA; PRIORITY JOURNAL; PROTHROMBIN TIME; URIC ACID BLOOD LEVEL;

EID: 0030767336     PISSN: 09396322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Pinto S, Abbate R, Rostagno C, Bruni V, Rosati D, Neri Serneri GG. Increased thrombin generation in normal pregnancy. Acta Eur Fertil 1988:19:263-7.
2. Stirling Y, Woolf L, North WRS, Segatchian MJ, Meade TW. Haemostasis in normal pregnancy. Thromb Haemost 1984:52:176-82.
3. Bonnar J. Haemostasis and coagulation disorders in pregnancy. In: Bloom AL, Thomas DP (eds): Edinburgh: 1987:570-84.
4. Bern MM. Acquired and congenital coagulation defects encountered during pregnancy and in the fetus. In: Bern MM, Frigoletto FD (eds): New York: 1990:395.
5. Comp PC, Thurnau GR, Welsh J, Esmon CT. Functional and immunologie protein S levels are decreased during pregnancy. Blood 1986; 68:881-5.
6. Gruel Y, Moalic P, Durouchet E, Guerois C, Delahousse B, Leroy J. Levels of total and free protein S during normal and pathological pregnancy and in post-partum. Thromb Haemost 1987;58:404 (Abstr).
7. Malm J. Laurell M, Dahlback B. Changes in the plasma levels of vitamin K-dependent protein C and S and of C4b-binding protein during pregnancy and oral contraception. Br J Haematol 1988:68:437-43.
8. Fernandez J, Estelles A, Gilabert J, Espana F, Aznar J. Functional and immunologie protein S in normal pregnant women and in full-term newborns. Thromb Haemost 1989;61:474-8.
9. Chmielewska J, Ranby M, Wiman B. Evidence for a rapid inhibitor to tissue plasminogen activator in plasma. Thromb Res 1983;31:427-36.
10. Aznar J, Gilabert J, Estelies A, Espana F. Fibrinolytic activity and protein C in preeclampsia. Thromb Haemost 1986;55:314-7.
11. Kruithof EKO, Tran-Thang C, Gudinchet A, Hauer J, Nicoloso G, Genton C, et al. Fibrinolysis in pregnancy: a study of plasminogen activator inhibitors. Blood 1987;69:460-6.
12. Wright JG, Cooper P, Astedt B, Lecander I, Wilde JT, Preston FE, et al. Fibrinolysis during normal human pregnancy: complex interrelationships between plasma levels of tissue plasminogen activator and inhibitors, and the euglobulin clot lysis time. Br J Haematol 1988; 69:253-8.
13. Estelies A, Gilabert J, Espana F, Aznar J, Gomez-Lechon MJ. Fibrinolysis in preeclampsia Fibrinolysis 1987; 1:209-13.
14. Estelies A, Gilabert J, Aznar J, Loskutoff DJ, Schleef RR. Changes in the plasma levels of type 1 and type 2 plasminogen activator inhibitors in normal pregnancy and in patients with severe preeclampsia. Blood 1989;74:1332-8.
15. de Boer K, Lecander I, ten Gate JW, Borm JJ, Treffers PE. Placentaltype plasminogen activator inhibitor in preeclampsia. Am J Obstet Gynecol 1988; 158:518-22.
16. De Wolf F, Robertson WB, Brosens. The ultrastructure of acute atherosis in hypertensive pregnancy. Am J Obstet Gynecol 1975; 123:164.
17. Cavanagh D, Kmuppel LA Preeclampsia and eclampsia. In: Iffy L, Kaminetzky H (eds): New York: 1981:1271.
18. Sundstrom S, Olsson M, Holmberg PA, Lecander I, Astedt B, Ranby M. Determination of PAI-1 activity in pregnancy plasma requires the use of single-chain tPA. Fibrinolysis 1988;2(suppl 1):35 (Abstr).
19. Jorgensen M, Philips M, Thorsen S, Selmer J, Zenthen J Plasminogen activator inhibitor-1 is the primary inhibitor of tissue-type plasminogen activator in pregnancy plasma. Thromb Haemost 1987 ;5 8:872-8.
20. Contractor SF, Holmes-levers E, Morgan A, Oakey M, Staines NA. A monoclonal antibody based solid-phase enzyme-binding assay to measure levels of placental alkaline phosphatase in serum of women during pregnancy. J Immunol Methods 1985;79:99-108.
21. Hill LM. Metabolism of uric acid in normal and toxemic pregnancy. Mayo Clin Proc 1978;53:743-51.
22. Weiner CP. The mechanism of reduced antithrombin III activity in women with preeclampsia. Obstet Gynecol 1988;72:847-9.
23. Caron C, Goudemand J, Marey A, Beague D, Ducroux G, Drouvin F. Are haemostatic and fibrinolytic parameters predictors of preeclampsia in pregnancy-associated hypertension? Thromb Haemost 1991;66: 410-4.